Navigation Links
Medication appears well-tolerated, beneficial in Huntington's disease patients
Date:2/8/2010

roup).

In addition, the treatment resulting in improved average scores on an evaluation measuring overall cognitive function. Scores of individuals in the placebo group remained steady over the study period.

"Taken together, our data suggest that latrepirdine, at a dosage of 20 milligrams three times daily, is well tolerated for 90 days in patients with Huntington's disease and may have a beneficial effect on cognition," the authors conclude. "Future studies of latrepirdine are planned to further evaluate the effect of latrepirdine on the cognitive and behavioral symptoms of Huntington's disease."


'/>"/>

Contact: Abena Foreman-Trice
abena@virginia.edu
434-243-2734
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
2. Manic phase of bipolar disorder benefits from breast cancer medication
3. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
4. Mayo Clinic study indicates medication for ADHD may help student outcomes
5. Diet and medications may assist prevention of prostate cancer
6. Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
7. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
8. Moses Taylor Hospital Automates Medication Reconciliation
9. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
10. Patients cant recall their medications to tell doctors
11. Patient Empowerment -- Medication Error
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... (PRWEB) August 22, 2014 Buying a policy ... adult who is unsure about available coverage types by insurers ... principal life insurance policy pricing to the public using its ... of this tool is free and is expected to promote ... to the public throughout the U.S. The system is designed ...
(Date:8/22/2014)... FL (PRWEB) August 22, 2014 Millennium Treatment ... marijuana, resulting in a high level of drug use among ... ages fight against drug addiction and work to minimize drug ... levels of alcohol and drug addiction in history. According to ... an estimated 23.9 million Americans aged 12 or older—or 9.2 ...
(Date:8/22/2014)... HealthDay Reporter FRIDAY, Aug. 22, ... on work disability chronically use powerful prescription painkillers, according ... 2007 and 2011, about 44 percent of people receiving ... each year. And the percentage using the drugs long-term ... in 2011. Experts said the trend is ...
(Date:8/22/2014)... know little about how Ebola is transmitted and harbor unfounded ... States, a new survey shows. About four in 10 ... major Ebola outbreak in the United States, and one-quarter are ... sick with the deadly virus in the next year, according ... However, those opinions don,t match reality, the Harvard researchers noted. ...
(Date:8/22/2014)... 2014 Natural Clear Vision , a ... his own vision from legally blind to perfect 20/20 vision ... review. , “There is a huge portion of the ... function, and most people just think that’s the way it ... that can be pretty risky at times,” reports Michaels. “This ...
Breaking Medicine News(10 mins):Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2
... RENO, Nev., Nov. 20 Employers Occupational,Health, ... (NYSE: EIG ), announced,today that it ... URAC, a,Washington, D.C.-based health care accrediting organization ... industry. URAC,s Case,Management Accreditation standards require companies ...
... known for years that psychological trauma that results ... change how a person responds to stress. Now, ... loved ones, life-threatening accidents and other such traumas ... survivor doesn,t develop a clinical disorder., "The findings ...
... assumed to be the top truants in American medicine, not ... less treatable. However, a new study by Dartmouth researchers suggests ... through the cracksat least when it comes to colorectal and ... types of cancer, the study found that urban patients tend ...
... Corporation,(Nasdaq: RGEN ) announced today that the Company President ... two upcoming,healthcare conferences in New York, NY. -- Lazard ... Wednesday, November 28, 2007 at 11:00 A.M. EST at ... Madison Avenue, New York, NY. -- BMO Capital Markets ...
... in Molecular Imaging Zone, FORT LAUDERDALE, Fla., ... Board: IMDS) a pioneer in laser,optical breast cancer ... cancer cases imaged with optical computed tomography,technologies at ... - 28. A CT,Laser Mammography (CTLM(R)) system and ...
... 21st, Prey Veng Province, PHNOM PENH, Cambodia, ... AIDS organization in the United,States, which operates free ... and Asia, is honored to announce the opening ... The facility, AHF,s seventh,in the country, opens Wednesday, ...
Cached Medicine News:Health News:Employers Occupational Health, Inc. Receives URAC Case Management Accreditation 2Health News:Rural patients' colon and lung cancers diagnosed earlier, Dartmouth research says 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 3Health News:Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly 2Health News:Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly 3Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 2Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 3Health News:AIDS Healthcare Foundation and NCHADS to Open the 7th collaborative ART Center in Pea Reang 4
(Date:8/22/2014)... Research and Markets  has announced the ... Tools & Technologies" report to their offering. ... products or you wish to expand your product line, ... is. The authors know you want to make effective ... to generate improved revenues and take market share from ...
(Date:8/22/2014)...   Zacks Equity Research highlights Epizyme (Nasdaq: EPZM ... Panera (Nasdaq: PNRA - Free Report ) as the Bear ... Amicus Therapeutics (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: ... - Free Report ). Here is a synopsis of ... : The biotech bull market is far from ...
(Date:8/22/2014)... August 22, 2014 ... Today Lincor announced general availability of ... that delivers a range of education, entertainment and clinical ...      (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , " ... of care patient engagement to bedside smart devices, " ...
Breaking Medicine Technology:Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Lincor Unveils Next Generation TV-based Patient Engagement Solution 2
... Biopharmaceuticals Plc, a,biopharmaceutical company focused on the development ... initiated a Phase II,equivalent study of MRX-4, in ... allergic rhinitis (AR). The two-arm, randomized, multi-dose,double-blind, placebo-controlled ... study is expected to be completed by the ...
... Society, American Society of Breast Surgeons and American College ... ... Oncology, SUNNYVALE, Calif., June 24 Xoft, Inc. today announced,the ... national Electronic Brachytherapy patient registry,under oversight from three national physician societies, ...
Cached Medicine Technology:Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis 2First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 2First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 3First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 4
Vial with 100 Urine Reagent Test Strips, tests for glucose, protein, pH, blood, ketone, bilirubin, nitrite, urobilinogen, specific gravity. FOR LABORATORY USE BY QUALIFIED TECHNICIANS....
... market-leading system for laboratory accreditation management, ... the UK and Ireland managing accreditation ... pathology laboratories worldwide, including Australia, Canada, ... United States trust and rely upon ...
... The Axioskop 40 FL laboratory microscope ... and mechanical stability of research-class instruments ... microscope is ideal for routine clinical ... hematology. In addition, it has numerous ...
... Our thawing systems are automated, easy to ... from the outside environment by flexible snap-seal ... bacterial or viral contamination of the water. ... the systems can also accommodate bags of ...
Medicine Products: